Screener
DiaMedica Therapeutics DMAC Q3 2025 earnings
Reported November 12, 2025 · After market close
EPS-$0.17Miss by $0.02
EPS estimate-$0.15
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$13.5M
EPS estimate-$0.20
Versus estimates
Diluted EPS
FAQ
- When did DiaMedica Therapeutics report Q3 2025 earnings?
- DiaMedica Therapeutics (DMAC) reported Q3 2025 earnings on November 12, 2025 after market close.
- What were DiaMedica Therapeutics's Q3 2025 revenue and EPS?
- DiaMedica Therapeutics reported eps of $-0.17 for Q3 2025.
- Did DiaMedica Therapeutics beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-0.15 by $0.02.
- How did DiaMedica Therapeutics's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 13.3% from $-0.15.
- Where can I find DiaMedica Therapeutics's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001437749-25-034467) and the 10-Q periodic report (0001437749-25-034469) directly on SEC EDGAR. The filing index links above go to sec.gov.
